Richard D. Berkowitz

Orthopedics
7171 N University Dr Ste 100
Tamarac, FL 33321

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Arthroplasty: A Randomized Trial Sub-Study.

Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Arthroplasty: A Randomized Trial Sub-Study.

Journal: Journal of pain & palliative care pharmacotherapy
Published: July 19, 2021

Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial.

Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial.

Journal: Pain medicine (Malden, Mass.)
Published: January 27, 2021

Meloxicam for intravenous use: review of its clinical efficacy and safety for management of postoperative pain.

Meloxicam for intravenous use: review of its clinical efficacy and safety for management of postoperative pain.

Journal: Pain management
Published: December 09, 2020

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.

Journal: Journal of pain research
Published: May 30, 2019

[(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection.

[(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection.

Journal: Nuclear medicine and biology
Published: September 29, 2015

Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: the Safe, Simple Transitions (SST) study.

Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: the Safe, Simple Transitions (SST) study.

Journal: Thrombosis research
Published: May 01, 2012
Showing 1-6 of 6

Last Updated: 09/26/2026